2018
Agreement in DNA methylation levels from the Illumina 450K array across batches, tissues, and time
Forest M, O'Donnell KJ, Voisin G, Gaudreau H, MacIsaac JL, McEwen LM, Silveira PP, Steiner M, Kobor MS, Meaney MJ, Greenwood CMT. Agreement in DNA methylation levels from the Illumina 450K array across batches, tissues, and time. Epigenetics 2018, 13: 19-32. PMID: 29381404, PMCID: PMC5837078, DOI: 10.1080/15592294.2017.1411443.Peer-Reviewed Original ResearchBrain-Derived Neurotrophic FactorCanadaCatechol O-MethyltransferaseDNA MethylationDried Blood Spot TestingEpigenesis, GeneticFemaleHumansMaleMouth MucosaNetherlandsOligonucleotide Array Sequence AnalysisReceptors, Dopamine D2Receptors, Dopamine D4Receptors, OxytocinReproducibility of ResultsSerotonin Plasma Membrane Transport ProteinsTime Factors
2014
Maternal prenatal anxiety and child brain-derived neurotrophic factor (BDNF) genotype: Effects on internalizing symptoms from 4 to 15 years of age
O'Donnell KJ, Glover V, Holbrook JD, O'Connor TG. Maternal prenatal anxiety and child brain-derived neurotrophic factor (BDNF) genotype: Effects on internalizing symptoms from 4 to 15 years of age. Development And Psychopathology 2014, 26: 1255-1266. PMID: 25422959, DOI: 10.1017/s095457941400100x.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAnxietyBehavioral SymptomsBrain-Derived Neurotrophic FactorChildChild, PreschoolEnglandFemaleGene-Environment InteractionGenotypeHumansLongitudinal StudiesPregnancyPregnancy ComplicationsConceptsBrain-derived neurotrophic factor (BDNF) genePrenatal maternal anxietyYears of agePrenatal anxietyBDNF polymorphismMaternal anxietyBrain-derived neurotrophic factor (BDNF) genotypeNeurotrophic factor genotypeInternalizing symptomsNeurotrophic factor geneAge 15 yearsAvon Longitudinal StudyMaternal prenatal anxietyMaternal symptomsChild internalizing symptomsGene-environment interactionsClinical InterviewPopulation cohortHealth outcomesSymptomsDiagnostic assessmentPsychosocial risksDifficulties QuestionnaireAge 13Longitudinal study